HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
LSE:HCM
Price:
324 GBX
-3.86%
Market Closed
Updated:
May 19, 2024
HUTCHMED (China) Ltd
Research & Development
|
HUTCHMED (China) Ltd
Research & Development Peer Comparison
Comparables:
G
512
U
3933
1177
C
570
C
3320
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
HUTCHMED (China) Ltd
LSE:HCM
|
Research & Development
-$302m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Research & Development
-¥757.2m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-21%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Research & Development
-¥4.4B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Research & Development
-¥685.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Research & Development
-HK$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Research & Development?
Research & Development
-302m
USD
-302m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Research & Development amounts to -302m USD.
What is HUTCHMED (China) Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-21%
-21%
Over the last year, the Research & Development growth was 22%. The average annual Research & Development growth rates for HUTCHMED (China) Ltd have been -20% over the past three years , -21% over the past five years .
You don't have any saved screeners yet
